Arteriocyte is now a part of Isto Biologics.

News + Views


ISTO Technologies Sponsors the Pediatric Orthopedic Project’s 5th Medical Mission Trip to the Dominican Republic

Apr 6, 2016

ISTO Technologies, Inc., a privately-held orthobiologic regenerative medicine company, is honored to support the mission of the Pediatric Orthopedic Project (POP) to treat needy children in the Dominican Republic. The POP team, led by Drs. Enrico and Madelyn Stazzone of St. Louis, traveled with a group of surgeons, nurses and other medical staff to Santiago, Dominican Republic for POP’s 5th mission trip in March. The team successfully performed seven orthopedic spine surgeries on children, trained local medical personnel, and completed facility improvements. ISTO sponsored this worthwhile cause by donating the orthobiologics products critical to healing these patients.

POP March 2016 Team
POP March 2016 Team

POP is a 501(c)3 non-profit organization based in St. Louis, dedicated to improving pediatric orthopedic care in developing nations. ISTO’s partnership with Dr. Stazzone began with his use of ISTO’s bone grafting products in his orthopedic spine practice. “I started using ISTO’s bone marrow and grafting products two years ago as biological enhancement for spinal fusions in complex scoliosis surgeries in children in the United States. At POP we strive to deliver the same level of care to our developing world patients as we do to those in the U.S. So it stands to reason that we would desire to utilize these products on our mission trips as well,” said Dr. Stazzone. Once ISTO learned of Dr. Stazzone’s efforts to improve the lives of children who don’t have access to this type of medical care, the St. Louis-based company offered to partner with him and support the POP. While in the Dominican Republic, Dr. Stazzone used InQu, a novel bone graft extender and substitute with a biosynthetic composition, to treat patients with scoliosis and spinal fractures. InQu supports new bone formation critical to patient healing, enabling Dr. Stazzone and his team to perform successful spine correction surgeries.

“Since both ISTO and POP have common goals of healing patients, this is an excellent partnership and one we are proud of,” said George Dunbar, CEO & President of ISTO Technologies. “We’re pleased to support Dr. Stazzone and the mission of the POP. ISTO has best-in-class orthobiologic products that can help improve quality of life for people around the world.”

“The 2016 mission trip team included 16 medical staff and volunteers. We performed six scoliosis surgeries and one spine trauma surgery at a local Children’s hospital in Santiago. Our team hosted four physician lectures, four nursing lectures and completed some hospital renovations to leave a lasting impact,” explained Dr. Stazzone, orthopedic surgeon and POP co-founder. “The trip was a success at every level—medical, relational, educational.”

To learn more about the Pediatric Orthopedic Project or read more details from their recent mission trip, visit the POP website.

About ISTO Technologies, Inc.

ISTO is a privately-held orthobiologics company dedicated to improving patient quality of life through the development of differentiated products for spinal therapies and sports medicine. The Company’s commercial portfolio of orthobiologic products is led by InQu®, a bone graft extender and substitute for spinal fusion applications that has been used in over 40,000 surgeries at U.S. hospitals to date.  In addition to its commercial portfolio, ISTO has a proprietary cell-based platform in clinical development which harnesses the regenerative capacity of juvenile cartilage cells to create products designed to repair damaged cartilage tissue and restore function.

For Additional Info Contact:
ISTO Technologies, Inc.
Jenny Reid, Marketing
Tel: (314) 995-6049

To top